Clinical trial

A Real-World Study in Patients With HR+/HER2- Advanced Breast Cancer

NCT07076680

StatusWITHDRAWN

Study typeOBSERVATIONAL

Start date2025-08-01

PhaseN/A

Study timeline

Study start (estimated)2025-08-01Date precision: day

Registry last updated2025-11-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer Metastaticunresolved

HR+/HER2- Advanced Breast Cancerunresolved

Interventions

Sponsors & collaborators

SciClone Pharmaceuticalslead sponsor

Mapped research locations

GuangzhouChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07076680 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.